•
Jun 30, 2022

Selecta Biosciences Q2 2022 Earnings Report

Total Revenue
$39.3M
Previous year: $19.7M
+99.7%
EPS
$0.06
0
Gross Profit
$39.3M
Previous year: $19.7M
+99.7%
Cash and Equivalents
$138M
Previous year: $126M
+9.8%
Free Cash Flow
-$12.4M
Previous year: -$6.66M
+85.7%
Total Assets
$188M
Previous year: $181M
+4.2%

Selecta Biosciences

Selecta Biosciences